# Haoben Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/haoben-biotechnology

- Industry: Materials
- Headquarters: Suzhou, China
- Latest round: Angel (Nov 21, 2023)
- Investors on record: 1

## About

Founded in 2020 and based in China, Haoben Biotechnology operates as a biotechnology company that focuses on the research and development of biomedical material. It collaborated with Tokyo Medical and Dental University, Osaka Institute of Technology, Shinshu University, Japan Institute of Biomaterials Engineering, Metropolitan Medical University, and Soka Life Sciences Co. In November 2023, it raised angel funding.

Haoben Biotechnology's main product is the preparation of decellularized matrix materials by hydrostatic pressure technology. The company obtained the decellularized matrix scaffolds by applying hydrostatic pressure to disrupt cell membranes in tissues and organs, and then using an elation solution to remove intracellular genetic material and other residues. It also provides regenerative therapeutic solutions for biologic tissue and organ repair for patients.

## Funding rounds

- Angel, Nov 21, 2023 — TiSiWi

## Investors

- TiSiWi (https://capitalatlas.ai/funds/tisiwi) — Angel